Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.

• Главные авторы: Sakib Burza (Автор), Prabhat K Sinha (Автор), Raman Mahajan (Автор), María Angeles Lima (Автор), Gaurab Mitra (Автор), Neena Verma (Автор), Manica Balasegaram (Автор), Pradeep Das (Автор)
• Формат: ‌
• Опубликовано: Public Library of Science (PLoS), 2014-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

BACKGROUND: A proportion of all immunocompetent patients treated for visceral leishmaniasis (VL) are known to relapse; however, the risk factors for relapse are not well understood. With the support of the Rajendra Memorial Research Institute (RMRI), Médecins Sans Frontières (MSF) implemented a pr...